Experiences and needs of people with haematological cancers during the COVID‐19 pandemic: A qualitative studyOriginal Article Published on 2021-09-092022-10-28 Journal: Psycho-oncology [Category] COVID-19, MERS, SARS, [키워드] addition analysed Cancer cancer patient Care Cell change changes connection COVID‐19 COVID‐19 pandemic disease distress Effect experience expressed Haematological cancer Haematology Health healthcare Immunocompromised impacted information interview management objective oncology pandemic participant Patient PROTECT psycho‐oncology qualitative research recommendation reduced Result risk Support supportive care transcript Travel Treatment worsened [DOI] 10.1002/pon.5819 PMC 바로가기 [Article Type] Original Article
Virtual Care in Patients with Cancer: A Systematic ReviewSystematic Review Published on 2021-09-082022-10-31 Journal: Current Oncology [Category] Coronavirus, SARS, [키워드] APA approach Cancer Care Clinical outcome Cochrane Library conducted counseling COVID-19 pandemic distress driven by evaluate Future Genetic Health knowledge non-randomized outcome OVID pandemic Patients with cancer Perceived stress phone Psychological Randomized controlled trials required Research review Satisfaction searched Support supportive care systematic review telehealth Telemedicine teleoncology usual care videoconferencing Virtual care [DOI] 10.3390/curroncol28050301 PMC 바로가기 [Article Type] Systematic Review
Treatment of moderate to severe respiratory COVID-19: a cost-utility analysisArticle Published on 2021-09-072022-10-04 Journal: Scientific Reports [Category] SARS, 임상, 치료법, 치료제, [키워드] adjusted Analysis Antimicrobial therapy calculated Care costly COVID-19 COVID-19 infection Critical Dexamethasone effective Health Health care economics healthcare hospital hospitalized patient Infectious diseases intensive care intubation less moderate moderate-severe morbidity and mortality oxygen Patient patients Perspective pharmacologic treatment Remdesivir required resource respiratory infection Respiratory tract diseases sensitivity analysis severe COVID-19 severe infections severity short duration Strategy Support supportive care the United State treatment for COVID-19 unlikely was performed with COVID-19 [DOI] 10.1038/s41598-021-97259-7 PMC 바로가기 [Article Type] Article
Update on Viral Infections Involving the Central Nervous System in Pediatric PatientsReview Published on 2021-09-062022-10-31 Journal: Children [Category] COVID-19, [키워드] age Analysis Antiviral approach caused Central nervous system central nervous system (CNS) infection cerebrospinal fluid children clinical feature clinically CNS CSF diagnostic Effectiveness Encephalitis evaluated Follow-up herpes simplex herpesviruses incidence indication Infection Involving lack life-threatening lumbar management Meningitis Mortality Neonatal nervous neurological occur Older pathogen Pathogens PCR pediatric infectious disease Pediatric patients performed polymerase chain prevalence rate Prognosis rehabilitation researcher selective supportive care System Therapies therapy to define Treatment treatment strategy viral infection virus viruses [DOI] 10.3390/children8090782 PMC 바로가기 [Article Type] Review
Role of rehabilitation amidst the COVID-19 pandemic: a reviewReview Published on 2021-09-042022-10-30 Journal: Journal of Translational Medicine [Category] COVID-19, SARS, [키워드] approach artificial intelligence Clinical course comparable COVID-19 COVID-19 patients curative treatment healthcare high risk increasingly Infectious disease Inpatients interactions mental health multiple organs outpatients Perspective physical physician problem PROTECT rehabilitation role Spread supportive care the disease Treatment [DOI] 10.1186/s12967-021-03048-1 PMC 바로가기 [Article Type] Review
Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital항바이러스 치료는 경증 COVID-19 관리에 임상적 이점을 제공할 수 없음: 현장 병원의 회고적 경험Article Published on 2021-09-012022-09-11 Journal: Journal of infection and public health [Category] SARS, 치료법, 치료제, [키워드] 95%CI abdominal pain acute respiratory distress acute respiratory distress syndrome Adverse drug reaction Adverse drug reactions affected age Antiviral antiviral drug antiviral drugs antiviral medication Antiviral treatment antiviral treatments Asymptomatic caused clinical benefit Clinical outcome clinical outcomes Complication coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 pneumonia Critical darunavir Darunavir-ritonavir death demonstrated diagnosed with COVID-19 diarrhea discharged home Disease progression evaluated experience Favipiravir field hospital Hepatitis hospital Hospital stay IQR Laboratory results Lopinavir Lopinavir-ritonavir Lopinavir/ritonavir males management median medical history Mild mild COVID-19 patient mild COVID-19 patients moderate past medical history Patient patients with asymptomatic Positive test receiving regimen respiratory distress Ritonavir Severe COVID-19 pneumonia significantly Standard standard supportive care supportive care Supportive treatment syndrome Treatment Treatment outcome university [DOI] 10.1016/j.jiph.2021.07.019 PMC 바로가기 [Article Type] Article
Visitation policies at NCI-designated comprehensive cancer centers during the COVID-19 pandemicObservational Study Published on 2021-09-012022-10-05 Journal: Supportive Care in Cancer [Category] 임상, [키워드] Abstract approach association Cancer Cancer center Care COVID-19 COVID-19 pandemic Critical Fisher geographic location implication infection control initial Inpatient lockdown lockdowns measure median time MOST n=36 oncology outcomes Outpatient Patient positive provide seeking severity Support supportive care visitation widespread [DOI] 10.1007/s00520-021-06183-z PMC 바로가기 [Article Type] Observational Study
Disseminated intravascular coagulation and its immune mechanismsResearch article Published on 2021-08-242022-10-05 Journal: Blood [Category] 비임상, [키워드] Activation Algorithm amplified Anticoagulant bleeding Blood coagulation Care characterized clinical clinical manifestation Coagulopathies Consumption consumptive Contact Critical Damage-associated molecular patterns Diagnosis disseminate dysregulation endothelial etiology Excessive activation expression fibrinogen homeostasis immune mechanism increased mortality Inflammatory Initiation intravascular coagulation mechanisms Microvascular thrombosis morbidity Mortality overlapping pathogenic mechanism pathologic pathology pathway Patient proteolytic reducing Regulatory supportive care syndrome thrombin tissue Trigger triggered vasculature widespread worsening [DOI] 10.1182/blood.2020007208 [Article Type] Research article
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusionSPIKE-1: SARS-CoV-2 스파이크 단백질 개시 막 융합을 차단하여 COVID-19의 임상 진행을 줄이는 데 camostat의 사용을 평가하는 커뮤니티 환경에서의 무작위 2상/3상 시험Letter Published on 2021-08-192022-09-10 Journal: Trials [Category] MERS, SARS, 임상, [키워드] 1:1 acute respiratory syndrome coronavirus apyrexia available data baseline best Biomarkers Blinding camostat clearance Clinical improvement clinical trial Community conducted control arm coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 symptom COVID-19 symptoms COVID-2019 Day defined Deterioration determined by diagnostics disease dissemination duration of illness Efficacy element eligibility criteria Eligible patients EudraCT evaluate Evidence evidence of Formal four times daily functional Guidance Health Organization health protection high risk hospital Hospital admission Hospital admissions Host include Infection initial Interactive Web Response System interim analysis Ireland IWRS Laboratory testing maximum membrane fusion moderate Mortality multicentre nasal negative swab number objective open open label Open-label Ordinal Scale outcome outcome measure overall mortality oxygen oxygen-free day Oxygenation participant Patient patient population patients with SARS-CoV-2 performed phase PK data Prevent primary care progression protection protocol provided Public Public Health Agency Public Health England qPCR questionnaire randomisation randomised randomised controlled trial receive recruit recruited recruitment reduce reducing refinement requiring supplemental oxygen Research respiratory risk RT-PCR Saliva Sample size Sample size calculations SARS-CoV-2 SARS-COV-2 infection secondary Secondary objective Secondary objectives secondary outcome measures serum antibody Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 severity spike status supplemental oxygen supplementary material supplementary oxygen supportive care Swab symptom severity tablets temperature the patient TMPRSS2 translational Translational research Treatment treatment arm Trial trial protocol Trial registration typical symptom typical symptoms upper respiratory Ventilation ventilator ventilator-free day Ventilator-free days Viral Viral load viral shedding website World Health Organization [DOI] 10.1186/s13063-021-05461-9 PMC 바로가기 [Article Type] Letter
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic Conclusions for crisis response at a high-volume oncology centerCOVID-19 대유행의 2차 유행 중 암 외래 환자의 SARS-CoV-2 스크리닝 고용량 종양 센터에서 위기 대응을 위한 결론Original Article Published on 2021-08-192022-09-10 Journal: Wiener Klinische Wochenschrift [Category] MERS, SARS, 치료기술, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adherence analyzed anticancer asymptomatic infection best Cancer cancer patient Cancer patient care coronavirus coronavirus disease Coronavirus disease 2019 Coverage COVID-19 COVID-19 pandemic First wave Follow-up highest indicate Infection information Odds ratio oncology Outpatient outpatient clinic outpatients pandemic parameter Patient patients performed Polymerase chain reaction (PCR) positive resource respiratory Result Safety measure SARS-CoV-2 SARS-CoV‑2 SARS-CoV‑2 infection SARS-CoV2 screening program second wave study period subsequent suffered supportive care tested Testing strategy Treatment was performed [DOI] 10.1007/s00508-021-01927-7 PMC 바로가기 [Article Type] Original Article